Usana Health Sciences, Inc., a Utah-based nutritional, skincare and dietary products manufacturer, indicates in its recently filed 8-K that it has substantially completed an internal investigation into whether the expense reimbursement policy and other practices at its Chinese affiliate, BabyCare Ltd., were compliant with the Foreign Corrupt Practices Act. The company reports that it is cooperating with the DOJ and the SEC in their investigations of the matter.
February 5, 2019
DOJ and SEC investigating nutritional supplement maker for possible FCPA violations
Related by Topic
DOJ requests early dismissal of Freepoint DPA
August 27, 2026
News Alert
DOJ’s Newly Established National Fraud Enforcement Division Announces New Structure and Five Priority Enforcement Areas
August 18, 2026
Insight
Federal jury finds former executive guilty of violating the FCPA
August 11, 2026
News Alert